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Just over a year ago we launched Stem Cell Research & 
Th erapy with the aim of it becoming the major forum for 
translational research into stem cell therapies [1]. As we 
celebrate our ﬁ rst year of publication we look back at 
what we have achieved and how we hope to progress in 
our second year and beyond.
Stem Cell Research & Th erapy is an international, peer-
reviewed, open access journal with a special emphasis on 
basic, translational, and clinical research into stem cell 
therapeutics, including animal models, and clinical trials. 
At launch we noted both the enormous potential of stem 
cell therapies and the major hurdles that have to be 
overcome [1]. While the past year has seen continued 
legal turmoil regarding governement funding of embry-
onic stem cell research in the USA [2], stem cell research 
continues to progress apace internationally.
Open access to research
In a fast-moving world the importance of research results 
being disseminated as quickly and widely as possible 
cannot be underestimated. All research articles published 
in Stem Cell Research & Th erapy are open access; they are 
freely available online from the moment of publication 
and universally accessible regardless of location, 
aﬃ  liation or ability to pay. Articles are archived in a 
number of open access repositories to ensure their 
permanent availability, including PubMed Central [3].
Wider distribution of their work is possible as authors 
retain the copyright of their article while allowing others 
to use and reproduce it with correct attribution. Open 
access publishing means research is much more visible 
both within the academic community and the wider 
population, and some studies have suggested that this 
increased availability may lead to an open access article 
being more likely to be cited [4].
Online publication allows us to measure the number of 
times an article has been accessed via the journal website. 
As research articles are open access and available via 
other sources, such as PubMed Central, overall accesses 
will be considerably higher, however these ﬁ gures are 
highly encouraging and indicate that our articles are 
being well-accessed. At the time of writing our most-
accessed research article is from Mohan Vemuri and 
colleagues, describing a novel serum-free mesenchymal 
stem cell culture medium which could substitute ill-
deﬁ ned traditional culture medium for research applica-
tions [5]. Th is article has been accessed more than 8000 
times via the journal website alone since its publication 
last year. Also featuring in our most-viewed articles are 
an article from Songtao Shi’s group demonstrating that 
transplanted stem cells from human exfoliated deciduous 
teeth can be used to treat systemic lupus erythematosus 
in a mouse model [6], and an evaluation of electro pora-
tion as a suitable method for reliable, eﬃ  cient trans-
fection of human embryonic stem cells from the group of 
Ronald Hart [7].
Informed and incisive commissioned content
In addition to open access research, Stem Cell Research & 
Th erapy publishes commissioned content including com-
pre hensive reviews of recent advances written by experts 
in the ﬁ eld, and speculative, opinionated commentaries. 
Our most-accessed article so far is a review by Danièle 
Noël and colleagues discussing the targets and mecha-
nisms of mesenchymal stem cell-mediated immunosup-
pres sion, and their potential use in a variety of auto-
immune diseases [8]. As well as stand-alone review 
articles, we also publish review series consisting of concise 
articles covering one aspect of a broader theme. A 
collection of articles on ‘Stem cell niche’ features a review 
from Gilbert and Blau on how combining stem cell 
biology and creative bioengineering technology could 
expand our understanding of regulation of the stem cell 
niche [9], and Sommer and Mostoslavsky summarized 
current reprogramming methodologies as part of our 
series on ‘Induced pluripotent stem cells’ [10]. We have 
recently published the ﬁ rst article [11] in our series on 
‘Immunology and stem cells,’ edited by Christian 
Jorgensen, and look forward to sharing with our readers 
the upcoming reviews in this series.© 2010 BioMed Central Ltd
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Looking ahead
It has been an exciting and productive ﬁ rst year for the 
journal and we would like to thank our Editorial Board, 
authors, reviewers and readers for their invaluable 
support. As ever we welcome your ideas, comments and 
suggestions on what the journal has, should, or could 
publish. Stem Cell Research & Th erapy has built a strong 
foundation and we look forward to its continued growth 
and recognition as a valued forum for the global stem cell 
research community.
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